AIDS News and Research

RSS

Fighting in the eastern Democratic Republic of Congo will affect HIV patients

Fighting in the eastern Democratic Republic of Congo (DRC) town of Bukavu - adjacent to the border with Rwanda - near the end of May has caused an MSF team there to seek refuge in the nearby UN compound.

1 Jun 2004

Physicians need to understand comorbidities to better help cancer patients

Findings from a new cancer study may seem obvious — a patient’s overall health is a critical factor in assessing prognosis. But the study’s authors say data about patients’ non-cancer ailments, called comorbidities, are not currently incorporated into cancer statistics.

27 May 2004

Blueprint for rational design of vaccines that induce desired T-cell responses

Investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have conducted studies in mice to gain a new picture of how the immune system’s “killer” T cells are prompted to destroy infected cells. Their insights provide a blueprint for rational design of vaccines that induce desired T-cell responses.

27 May 2004

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

27 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

$3.5 million grant to develop AIDS vaccinations

Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.

25 May 2004

Toxoplasma gondii discovery may help fight against malaria

University of North Carolina at Chapel Hill scientists have discovered a protein in the cell wall of parasites that’s crucial to the molecular mechanism allowing them to move between cells, survive and cause disease.

25 May 2004

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles.

24 May 2004

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.

22 May 2004

Diabetes drug improves metabolic changes associated with HIV combination therapy

Use of an oral antidiabetes medication produced significant improvement in a group of patients with HIV lipodsytrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

20 May 2004

Britain's youth complacent about HIV/AIDS

New data from surveys across the UK reveal a decline in 12-15 year olds’ knowledge about the dangers of HIV/AIDS. Figures from 1995-2001, (see tables), using a sample of 142,281 young people, show a declining trend of youngsters who think that HIV can be passed on by:

19 May 2004

Canadian Statement to the World Health Assembly focuses on AIDS

The WHO's leadership is particularly important in the fight to combat HIV/AIDS. Last week, Canada bolstered its financial commitment to this effort with contributions of $100 million for WHO's '3 by 5 initiative', and $70 million to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. Canada and Canadians are proud to take these actions against HIV/AIDS.

19 May 2004

50 new scientists sought after in the field of biomedical research

The Institute is looking for candidates from the full range of biological and biomedical inquiry who demonstrate exceptional promise early in their careers as independent researchers. Nearly 200 universities, medical schools, and research institutes have been invited to nominate their best scientists for the competition. Between 30 and 50 scientists will be chosen to join the Institute in 2005.

19 May 2004

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Current treatments for HIV block the virus from replicating, but don’t kill the cells that contain HIV. The existence of these HIV-harboring cells -- often called the “latent” or “resting reservoir” -- is regarded by many to be the main obstacle to finding a cure for HIV.

18 May 2004

UN round table looks at rapid spread of HIV/AIDS in prisons

The rapid spread of HIV/AIDS in prisons, and practical measures to curb the spread of the disease in this section of society was the subject of a round table organized today by the United Nations Office on Drugs and Crime (UNODC) and attended by high-level international experts.

17 May 2004

Study examines impact of cochlear implants

Cochlear implants are small electronic devices that are surgically implanted in the ear, aiding those deaf people not helped by traditional hearing aids. Approximately 90 percent of parents who have deaf children are not deaf, and generally have had little, if any, experience with deaf persons or understanding of deafness. However, perceptions may be changing, partially due to new research on the implants, the article states.

17 May 2004

Speaking their language aids dementia patients

Elderly dementia patients from non-English speaking backgrounds communicate more with others and take fewer psychiatric medications when living in ethno-specific nursing homes, an Australian study at Monash University has revealed.

17 May 2004

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

GlaxoSmithKline plc and Boehringer Ingelheim announced today that both companies welcome the United States' continued involvement in the global response to HIV/AIDS.

17 May 2004

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

New international consensus guidelines for FUZEON (enfuvirtide) are published today in AIDS, the official journal of the International AIDS Society.

17 May 2004

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

HHS Secretary Tommy G. Thompson today announced an expedited review process to ensure that the United States is providing safe, effective drugs to developing countries under the President's $15 billion Emergency Plan for AIDS Relief.

16 May 2004